Eisler Capital (Uk) Ltd. Pfizer Inc Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $837,343 - $948,888	30,229 Added 3.97%	791,705 $22.9 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $5.86 Million - $6.87 Million	232,179 Added 43.87%	761,476 $21.3 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $4.94 Million - $5.68 Million	190,955 Added 56.44%	529,297 $14.7 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $5.65 Million - $7.33 Million	216,036 Added 176.64%	338,342 $9.74 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $3.92 Million - $4.59 Million	122,306 New	122,306 $4.06 Million

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.